Publication Category

Cost of Dialysis Therapy by Modality in Manitoba

Beaudry, A, Ferguson, T, Rigatto, C, Tangri, N, Dumanski, S, Komenda, P.

Clinical Journal of the American Society of Nephrology

Study Description

The prevalence of ESKD is increasing worldwide. Treating ESKD is disproportionately costly in comparison with its prevalence, mostly due to the direct cost of dialysis therapy. Here, we aim to provide a contemporary cost description of dialysis modalities, including facility-based hemodialysis, peritoneal dialysis, and home hemodialysis, provided with conventional dialysis machines and the NxStage System One.


Research Division · Seven Oaks Chronic Disease Innovation Centre
2300 McPhillips Street · Winnipeg, Manitoba · R2V 3M3 · 204‑631‑3834